Virtual coach aims to boost diversity in cancer trials

NCT ID NCT07126496

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a virtual community health educator (vCHE) can increase referrals to cancer clinical trials among diverse populations. Researchers will enroll 2,000 cancer patients and their caregivers across Florida. Participants interact with a computer-based agent that provides culturally tailored information in English or Spanish. The goal is to see if this approach can help underrepresented groups learn about and join cancer trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Virtual community health educator (vCHE) - a computer-based agent providing tailored information
What this could lead to
If successful, this could show that virtual health educators are a cost-effective way to increase diverse participation in cancer clinical trials, helping reduce health disparities.
What could go wrong
This is an early-stage study focused on referrals, not treatment outcomes. It may not prove that vCHEs actually improve trial enrollment or health results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mayo Clinic in Florida

    RECRUITING

    Jacksonville, Florida, 32224-9980, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.